Proyectos por año
Perfil personal
Experiencia relacionada con los ODS de las Naciones Unidas
En 2015, los estados miembros de las Naciones Unidas acordaron 17 Objetivos de Desarrollo Sostenible (ODS) para erradicar la pobreza, proteger el planeta y garantizar la prosperidad para todos. El trabajo de esta persona contribuye al logro de los siguientes ODS:
Cuantificación de educación / académica
Post Doctoral Fellow, Stanford University
2019
Post Doctoral Fellow, New York Medical College
2018
Residency, New York Medical College
2015
Bachelor of Medicine, Bachelor of Surgery, Stanley Medical College
2011
Huella digital
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
-
25-NHL-45-CC (CA0731003): A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator s Choice in Participants with Relapsed/Refractory Follicular Lymphom
Iragavarapu, C. (PI)
8/28/25 → 8/28/27
Proyecto: Research project
-
24-NHL-41-MSD (MK-2140-010-00): A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)
Iragavarapu, C. (PI)
Merck Sharp & Dohme Corporation
7/7/25 → 7/7/27
Proyecto: Research project
-
25-NHL-43-JJ-PMC (90014496LYM1001): A Phase 1b Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants with B-cell Non-Hodgkin Lymphoma
Iragavarapu, C. (PI)
Janssen Research and Development LLC
5/22/25 → 5/22/27
Proyecto: Research project
-
25-NHL-44-HR(GO45434): A Phase II, Open-Label, Multicenter Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cel
Iragavarapu, C. (PI)
4/28/25 → 4/28/27
Proyecto: Research project
-
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients
Yalniz, F. F., Johnson, A., Alnimer, Y., Chahine, Z., Morris, T., Yadav, R., Taj, H., Iragavarapu, C., Munker, R., Monohan, G., Wai, S., Zhang, S., Nozad, S. & Qasrawi, A., feb 2025, En: European Journal of Haematology. 114, 2, p. 365-372 8 p.Producción científica: Article › revisión exhaustiva
-
Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma
Weng, W. K., Iragavarapu, C., Weng, G. M., Hoppe, R. T., Hiniker, S., Khodadoust, M. S. & Kim, Y. H., jun 2024, En: Blood Neoplasia. 1, 2, 100007.Producción científica: Article › revisión exhaustiva
Acceso abierto3 Citas (Scopus) -
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience
Curry, L. D., Munker, R., Li, N., Yan, D., Pryor, P., Nozad, S., Keller, P., Monohan, G. P., Iragavarapu, C. & Krem, M. M., ene 2023, En: Annals of Hematology. 102, 1, p. 141-154 14 p.Producción científica: Article › revisión exhaustiva
9 Citas (Scopus) -
AML-434 Retrospective Review of Outcomes in Newly Diagnosed Leukemia Patients Aged 65 and Older When Admitted to the Hospital: A Single Center Experience
Canter, C., Hildebrandt, G., Iragavarapu, C., Munker, R., Qasrawi, A., Ramlal, R. & Monohan, G., oct 2022, En: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S250Producción científica: Article › revisión exhaustiva
-
Multimodality Imaging Guided Diagnosis and Treatment Response Evaluation in a Patient with Lymphoma with Right Atrioventricular Involvement
Chen, J., Ahmed, T., Ahmed, T., Iragavarapu, C., Ramlal, R. & Arbune, A., sept 2022, En: Current Problems in Cardiology. 47, 9, 101273.Producción científica: Review article › revisión exhaustiva
1 Cita (Scopus)